LE WE PMID CA
Diabetes mellitus T2DM (Type2)678Diabetes mellitus (Typ2)

alpha Glucosidase

AMP activated protein kinase

Amylin

Arterial hypertension (BASKET)

beta cell (Pancreas)

Cdkal1

Cell stress (ER stress)

Dapagliflozin

Diabetes mellitus (Childhood)

Diabetes mellitus (t Incretins)

Diabetes mellitus (t Insulin Analogs)

Diabetes mellitus T1DM (Type1)

Diabetes mellitus T2DM (Type2)

Exercise (Physiology)

Genetics (GWAS Genome wide association study)

Glucagon

IMP2 IGF2BP2

Ketoacidosis

Kidney (Tubulus)

Laboratory animal (BASKET)

Liraglutide

Mitochondria (BASKET)

NAMPT

Polyamines

Premedication and perioperative medicine

RAAS (Renin angiotensin system)

Receptor (Sulfonylurea)

RNA (tRNA)

SIRT1

SLC5A2 SGLT2

SUR

Testosterone

Transporter (Sodium and glucose)

Unfolded protein response

2008  
1
Prediabetes: prevalent and preventable but underdiagnosed and undertreated.
[19127764] Manag Care 17(12): 33-4, 40 (2008)
2009  
2
Redefining the role of thiazolidinediones in the management of type 2 diabetes.
[19436665] Vasc Health Risk Manag 5(1): 141-51 (2009)
2007  
3
Optimizing combination treatment in the management of type 2 diabetes.
[18078018] Vasc Health Risk Manag 3(5): 665-71 (2007)
2010  
4
Self-monitoring of blood glucose in type 2 diabetes: systematic review.
[20226138] Health Technol Assess 14(12): 1-140 (2010)
2008  
5
The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.
[18405469] Health Technol Assess 12(9): 1-116, iii (2008)
2008  
6
Cost-effectiveness of insulin analogs.
[18999911] Am J Manag Care 14(11): 766-75 (2008)
2008  
7
Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
[18197742] Am J Manag Care 14(1): 25-30 (2008)
2005  
8
A systematic review of diabetes disease management programs.
[15839184] Am J Manag Care 11(4): 242-50 (2005)
2003  
9
Prevention of the complications of diabetes.
[12653455] Am J Manag Care 9(3 Suppl): S63-80; quiz S81-4 (2003)
2002  
10
Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
[12408409] Am J Manag Care 8(16 Suppl): S460-71 (2002)
1997  
11
Diabetes management: current diagnostic criteria, drug therapies, and state legislation.
[10178463] Am J Manag Care 3(10): 1599-608; quiz 1161-4 (1997)
1974  
12
Manifestations of diabetes mellitus--their possible relationships to an underlying cell defect. A review.
[4596653] Am J Pathol 75(1): 204-24 (1974)
2008  
13
Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
[18794553] Ann Intern Med 149(8): 549-59 (2008)
2007  
14
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
[17638715] Ann Intern Med 147(6): 386-99 (2007)
2006  
15
Narrative review: a rational approach to starting insulin therapy.
[16847295] Ann Intern Med 145(2): 125-34 (2006)
1988  
16
The biochemistry of diabetes.
[3291853] Biochem J 250(3): 625-40 (1988)
1964  
17
DIABETES MELLITUS. A REVIEW OF SOME RECENT INVESTIGATIONS INTO THE NATURE OF THE CLINICAL SYNDROME.
[14106540] Calif Med 100(-): 1-9 (1964)
2005  
18
Diagnosis and classification of diabetes mellitus.
[15618111] Diabetes Care 28 Suppl 1(-): S37-42 (2005)
2004  
19
2004  
20
Diagnosis and classification of diabetes mellitus.
[14693921] Diabetes Care 27 Suppl 1(-): S5-S10 (2004)
2003  
21
Pharmacologic treatment of type 2 diabetes.
[12547894] Diabetes Care 26(2): 526-33 (2003)
2003  
22
Report of the expert committee on the diagnosis and classification of diabetes mellitus.
[12502614] Diabetes Care 26 Suppl 1(-): S5-20 (2003)
2002  
23
Standards of medical care for patients with diabetes mellitus.
[11772918] Diabetes Care 25(1): 213-29 (2002)
2006  
24
Postprandial hyperglycaemia: to treat or not to treat?
[16735958] Diabetes Metab 32(2): 105-11 (2006)
2006  
25
Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities.
[16523182] Diabetes Metab 32(1): 7-13 (2006)
2005  
26
Use of antidiabetic drugs in elderly patients.
[16415772] Diabetes Metab 31 Spec No 2(-): 5S98-5S104 (2005)
2005  
27
An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives.
[15959415] Diabetes Metab 31(2): 101-9 (2005)
2008  
28
Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.
[18782870] J Clin Endocrinol Metab 93(12): 4633-42 (2008)
2008  
29
Approach to the patient with prediabetes.
[18772457] J Clin Endocrinol Metab 93(9): 3259-65 (2008)
2008  
30
A new look at screening and diagnosing diabetes mellitus.
[18460560] J Clin Endocrinol Metab 93(7): 2447-53 (2008)
2002  
31
Clinical review 146: The impact of clinical trials on the treatment of diabetes mellitus.
[11994319] J Clin Endocrinol Metab 87(5): 1929-37 (2002)
2001  
32
Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.
[11549624] J Clin Endocrinol Metab 86(9): 4047-58 (2001)
1999  
33
Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment.
[10199747] J Clin Endocrinol Metab 84(4): 1165-71 (1999)
2006  
34
Islet beta cell failure in type 2 diabetes.
[16823478] J Clin Invest 116(7): 1802-12 (2006)
1987  
35
Lipoprotein metabolism in diabetes mellitus.
[3302085] J Lipid Res 28(6): 613-28 (1987)
2005  
36
Insulin glargine: a long acting insulin analog.
[15793346] J Postgrad Med 51(1): 68-71 (2005)
2003  
37
Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
[12683698] Mayo Clin Proc 78(4): 459-67 (2003)
2003  
38
Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.
[12683697] Mayo Clin Proc 78(4): 447-56 (2003)
1994  
39
New concepts in diabetes mellitus. II: Complications.
[7937425] Postgrad Med J 70(825): 479-85 (1994)
1994  
40
New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.
[8029161] Postgrad Med J 70(824): 418-27 (1994)
1990  
41
1985  
42
Polyamines in clinical disorders.
[3976221] West J Med 142(1): 63-73 (1985)
2009  
43
Cost-effectiveness of insulin analogues for diabetes mellitus.
[19221353] CMAJ 180(4): 400-7 (2009)
2009  
44
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.
[19221352] CMAJ 180(4): 385-97 (2009)
2005  
45
Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.
[16293781] CMAJ 173(12): 1457-66 (2005)
1991  
46
Non-insulin-dependent (type II) diabetes mellitus.
[1742694] CMAJ 145(12): 1571-81 (1991)
2010  
47
Starting insulin therapy for type-2 diabetes.
[20513939] Acta Med Indones 42(2): 116-20 (2010)
2002  
48
Alternative therapies for type 2 diabetes.
[11896745] Altern Med Rev 7(1): 45-58 (2002)
2010  
49
The effects of biofeedback in diabetes and essential hypertension.
[20622080] Cleve Clin J Med 77 Suppl 3(-): S68-71 (2010)
2011  
50
Insulin treatment for type 2 diabetes: when to start, which to use.
[21536829] Cleve Clin J Med 78(5): 332-42 (2011)
2011  
51
How to manage type 2 diabetes in medical and surgical patients in the hospital.
[21632909] Cleve Clin J Med 78(6): 379-84 (2011)
2009  
52
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
[19952298] Cleve Clin J Med 76 Suppl 5(-): S12-9 (2009)
2009  
53
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects.
[19952302] Cleve Clin J Med 76 Suppl 5(-): S39-47 (2009)
2009  
54
Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
[19952303] Cleve Clin J Med 76 Suppl 5(-): S4-11 (2009)
2009  
55
Managing diabetes in hemodialysis patients: observations and recommendations.
[19884294] Cleve Clin J Med 76(11): 649-55 (2009)
2011  
56
Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.
[21270290] Mayo Clin Proc 86(2): 128-38 (2011)
2010  
57
Defining and achieving treatment success in patients with type 2 diabetes mellitus.
[21106864] Mayo Clin Proc 85(12 Suppl): S50-9 (2010)
2009  
58
Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
[19015168] Nephrol Dial Transplant 24(2): 338-41 (2009)
2009  
59
Management of progressive type 2 diabetes: role of insulin therapy.
[19573240] Osteopath Med Prim Care 3(-): 5 (2009)
2010  
60
Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.
[20739389] J Clin Endocrinol Metab 95(9): 4206-16 (2010)
2009  
61
Update on nonautoimmune diabetes in children.
[19584196] J Clin Endocrinol Metab 94(7): 2215-20 (2009)
2002  
62
Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models.
[12201207] Endocr J 49(3): 247-63 (2002)
2011  
63
Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes [Review].
[21908934] Endocr J 58(10): 819-25 (2011)
2011  
64
Genetics of type 2 diabetes: the GWAS era and future perspectives [Review].
[21778616] Endocr J 58(9): 723-39 (2011)
2007  
65
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
[17613449] Endocr Pract 13 Suppl 1(-): 1-68 (2007)
2009  
66
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
[19858063] Endocr Pract 15(6): 540-59 (2009)
2010  
67
The role of mitochondria in the pathogenesis of type 2 diabetes.
[20156986] Endocr Rev 31(3): 364-95 (2010)
2008  
68
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
[18314421] Endocr Rev 29(3): 303-16 (2008)
2008  
69
Syndromes of ketosis-prone diabetes mellitus.
[18292467] Endocr Rev 29(3): 292-302 (2008)
2008  
70
Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.
[18292465] Endocr Rev 29(3): 367-79 (2008)
2008  
71
The role for endoplasmic reticulum stress in diabetes mellitus.
[18048764] Endocr Rev 29(1): 42-61 (2008)
2008  
72
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.
[18436705] Endocr Rev 29(3): 317-33 (2008)
2009  
73
Pathomechanisms of type 2 diabetes genes.
[19749172] Endocr Rev 30(6): 557-85 (2009)
2011  
74
A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.
[21447284] Discov Med 11(58): 255-63 (2011)
2009  
75
Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.
[19466209] Arq Bras Endocrinol Metabol 53(2): 165-74 (2009)
2007  
76
Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
[17619673] Aust Fam Physician 36(7): 549-53 (2007)
2007  
77
Animal models in type 2 diabetes research: an overview.
[17496368] Indian J Med Res 125(3): 451-72 (2007)
2009  
78
The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
[18772488] J Androl 30(1): 23-32 (2009)
2009  
79
Complementary and alternative medicine for the treatment of type 2 diabetes.
[19509199] Can Fam Physician 55(6): 591-6 (2009)
2009  
80
Targeting the AMPK pathway for the treatment of Type 2 diabetes.
[19273282] Front Biosci 14(-): 3380-400 (2009)
2009  
81
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.
[19273250] Front Biosci 14(-): 2983-95 (2009)
2008  
82
New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.
[18309002] Clin J Am Soc Nephrol 3 Suppl 2(-): S38-48 (2008)
2006  
83
Ketosis-prone type 2 diabetes: time to revise the classification of diabetes.
[17130220] Diabetes Care 29(12): 2755-7 (2006)
2005  
84
Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
[15616251] Diabetes Care 28(1): 154-63 (2005)
2010  
85
Pediatric endocrinologists' management of children with type 2 diabetes.
[20007947] Diabetes Care 33(3): 512-4 (2010)
2008  
86
Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
[18227479] Diabetes Care 31 Suppl 2(-): S161-4 (2008)
2010  
87
Current views on type 2 diabetes.
[19770178] J Endocrinol 204(1): 1-11 (2010)
2010  
88
Liraglutide in the management of type 2 diabetes.
[21116334] Drug Des Devel Ther 4(-): 279-90 (2010)
2010  
89
Epigenetic mechanisms in the development of type 2 diabetes.
[19864158] Trends Endocrinol Metab 21(4): 223-9 (2010)
2002  
90
Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
[11938023] Diabetes Metab 28(1): 14-9 (2002)
2010  
91
Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia.
[21211733] Diabetes Metab 36 Suppl 3(-): S31-8 (2010)
2004  
92
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.
[15671918] Diabetes Metab 30(6): 487-96 (2004)
2004  
93
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
[15671919] Diabetes Metab 30(6): 498-505 (2004)
2008  
94
Pancreatic alpha-cell dysfunction in diabetes.
[18640586] Diabetes Metab 34 Suppl 2(-): S49-55 (2008)
2011  
95
Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document.
[21270909] Nefrologia 31(1): 17-26 (2011)
2007  
96
Rapid onset of coma and death in the initial presentation of type 2 diabetes in an 11-year-old child.
[19030339] Paediatr Child Health 12(1): 41-2 (2007)
2010  
97
2008  
98
Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes.
[18212763] Nat Clin Pract Endocrinol Metab 4(3): 164-72 (2008)
2008  
99
2011  
100
2011 clinical practice guidelines for type 2 diabetes in Korea.
[22111032] Diabetes Metab J 35(5): 431-6 (2011)
2009  
101
Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies.
[19801365] J Am Pharm Assoc (2003) 49 Suppl 1(-): S3-9 (2009)
2009  
102
IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes.
[19429674] J Mol Endocrinol 43(5): 187-95 (2009)
2007  
103
Prevention and treatment of type 2 diabetes in youth.
[17008794] Horm Res 67(1): 22-34 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2


  • Search PubMed and many other databases on the combined search terms

    GG: diabetes mellitus type 2
    GG: t2dm

  • Diabetes mellitus (Typ2)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia